{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:40:01Z","timestamp":1794336001407,"version":"4.9.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12879-014-0647-4","type":"journal-article","created":{"date-parts":[[2014,12,13]],"date-time":"2014-12-13T13:34:47Z","timestamp":1418477687000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Clinical and microbiological characteristics of bloodstream infections due to AmpC \u03b2-lactamase producing Enterobacteriaceae: an active surveillance cohort in a large centralized Canadian region"],"prefix":"10.1186","volume":"14","author":[{"given":"Vikas P","family":"Chaubey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann D D","family":"Pitout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Dalton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel B","family":"Gregson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin B","family":"Laupland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,14]]},"reference":[{"issue":"4","key":"647_CR1","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1056\/NEJMra041359","volume":"352","author":"GA Jacoby","year":"2005","unstructured":"Jacoby GA, Munoz-Price LS: The new beta-lactamases. N Engl J Med. 2005, 352 (4): 380-391. 10.1056\/NEJMra041359.","journal-title":"N Engl J Med"},{"issue":"1","key":"647_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","volume":"46","author":"A Philippon","year":"2002","unstructured":"Philippon A, Arlet G, Jacoby GA: Plasmid-determined AmpC-type beta-lactamases. Antimicrob Agents Chemother. 2002, 46 (1): 1-11. 10.1128\/AAC.46.1.1-11.2002.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"647_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1128\/AAC.49.1.358-365.2005","volume":"49","author":"MR Mulvey","year":"2005","unstructured":"Mulvey MR, Bryce E, Boyd DA, Ofner-Agostini M, Land AM, Simor AE, Paton S: Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother. 2005, 49 (1): 358-365. 10.1128\/AAC.49.1.358-365.2005.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"647_CR4","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1046\/j.1469-0691.2002.00492.x","volume":"8","author":"FW Goldstein","year":"2002","unstructured":"Goldstein FW: Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation. Clin Microbiol Infect. 2002, 8 (12): 823-825. 10.1046\/j.1469-0691.2002.00492.x.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"647_CR5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1128\/CMR.00036-08","volume":"22","author":"GA Jacoby","year":"2009","unstructured":"Jacoby GA: AmpC beta-lactamases. Clinical microbiology reviews. 2009, 22 (1): 161-182. 10.1128\/CMR.00036-08. Table of Contents","journal-title":"Clinical microbiology reviews"},{"issue":"1","key":"647_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1469-0691.2004.00831.x","volume":"10","author":"DM Livermore","year":"2004","unstructured":"Livermore DM, Brown DF, Quinn JP, Carmeli Y, Paterson DL, Yu VL: Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae?. Clin Microbiol Infect. 2004, 10 (1): 84-85. 10.1111\/j.1469-0691.2004.00831.x.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"647_CR7","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/clinids\/10.4.830","volume":"10","author":"WE Sanders Jr","year":"1988","unstructured":"Sanders WE, Sanders CC: Inducible beta-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. Rev Infect Dis. 1988, 10 (4): 830-838. 10.1093\/clinids\/10.4.830.","journal-title":"Rev Infect Dis"},{"key":"647_CR8","volume-title":"Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement M100-S20","author":"Clinical and Laboratory Standards Institute","year":"2010","unstructured":"Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement M100-S20. 2010, Clinical and Laboratory Standards Institute, Wayne, PA"},{"issue":"6","key":"647_CR9","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1097\/01.CCM.0000217961.75225.E9","volume":"34","author":"A Kumar","year":"2006","unstructured":"Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, Suppes R, Feinstein D, Zanotti S, Taiberg L, Gurka D, Kumar A, Cheang M: Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006, 34 (6): 1589-1596. 10.1097\/01.CCM.0000217961.75225.E9.","journal-title":"Crit Care Med"},{"issue":"8","key":"647_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","volume":"115","author":"JW Chow","year":"1991","unstructured":"Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL: Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991, 115 (8): 585-590. 10.7326\/0003-4819-115-8-585.","journal-title":"Ann Intern Med"},{"issue":"9","key":"647_CR11","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1128\/AAC.45.9.2628-2630.2001","volume":"45","author":"KS Kaye","year":"2001","unstructured":"Kaye KS, Cosgrove S, Harris A, Eliopoulos GM, Carmeli Y: Risk factors for emergence of resistance to broad-spectrum cephalosporins among Enterobacter spp. Antimicrob Agents Chemother. 2001, 45 (9): 2628-2630. 10.1128\/AAC.45.9.2628-2630.2001.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"647_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1001\/archinte.162.2.185","volume":"162","author":"SE Cosgrove","year":"2002","unstructured":"Cosgrove SE, Kaye KS, Eliopoulous GM, Carmeli Y: Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. Arch Intern Med. 2002, 162 (2): 185-190. 10.1001\/archinte.162.2.185.","journal-title":"Arch Intern Med"},{"issue":"3","key":"647_CR13","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1128\/AAC.01083-07","volume":"52","author":"SH Choi","year":"2008","unstructured":"Choi SH, Lee JE, Park SJ, Choi SH, Lee SO, Jeong JY, Kim MN, Woo JH, Kim YS: Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use. Antimicrob Agents Chemother. 2008, 52 (3): 995-1000. 10.1128\/AAC.01083-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"647_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1093\/jac\/11.4.299","volume":"11","author":"B Olson","year":"1983","unstructured":"Olson B, Weinstein RA, Nathan C, Kabins SA: Broad-spectrum beta-lactam resistance in Enterobacter: emergence during treatment and mechanisms of resistance. J Antimicrob Chemother. 1983, 11 (4): 299-310. 10.1093\/jac\/11.4.299.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"647_CR15","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1086\/653207","volume":"31","author":"J Leal","year":"2010","unstructured":"Leal J, Gregson DB, Ross T, Flemons WW, Church DL, Laupland KB: Development of a novel electronic surveillance system for monitoring of bloodstream infections. Infect Control Hosp Epidemiol. 2010, 31 (7): 740-747. 10.1086\/653207.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"11","key":"647_CR16","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005, 43 (11): 1130-1139. 10.1097\/01.mlr.0000182534.19832.83.","journal-title":"Med Care"},{"issue":"12","key":"647_CR17","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1097\/MLR.0b013e3181484347","volume":"45","author":"V Sundararajan","year":"2007","unstructured":"Sundararajan V, Quan H, Halfon P, Fushimi K, Luthi JC, Burnand B, Ghali WA, International Methodology Consortium for Coded Health I: Cross-national comparative performance of three versions of the ICD-10 Charlson index. Med Care. 2007, 45 (12): 1210-1215. 10.1097\/MLR.0b013e3181484347.","journal-title":"Med Care"},{"issue":"11","key":"647_CR18","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1111\/j.1469-0691.2008.02089.x","volume":"14","author":"KB Laupland","year":"2008","unstructured":"Laupland KB, Gregson DB, Church DL, Ross T, Pitout JD: Incidence, risk factors and outcomes of Escherichia coli bloodstream infections in a large Canadian region. Clin Microbiol Infect. 2008, 14 (11): 1041-1047. 10.1111\/j.1469-0691.2008.02089.x.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"647_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/j.1469-0691.2009.02756.x","volume":"16","author":"JD Pitout","year":"2010","unstructured":"Pitout JD, Le PG, Moore KL, Church DL, Gregson DB: Detection of AmpC beta-lactamases in Escherichia coli, Klebsiella spp., Salmonella spp. and Proteus mirabilis in a regional clinical microbiology laboratory. Clin Microbiol Infect. 2010, 16 (2): 165-170. 10.1111\/j.1469-0691.2009.02756.x.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"647_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S0732-8893(97)00064-3","volume":"28","author":"MA Pfaller","year":"1997","unstructured":"Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, Wenzel RP: Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE). Diagn Microbiol Infect Dis. 1997, 28 (4): 211-219. 10.1016\/S0732-8893(97)00064-3.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"2","key":"647_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0924-8579(03)00094-3","volume":"22","author":"BN Kim","year":"2003","unstructured":"Kim BN, Lee SO, Choi SH, Kim NJ, Woo JH, Ryu J, Kim YS: Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species. Int J Antimicrob Agents. 2003, 22 (2): 106-111. 10.1016\/S0924-8579(03)00094-3.","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"647_CR22","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1592\/phco.27.2.191","volume":"27","author":"EN Deal","year":"2007","unstructured":"Deal EN, Micek ST, Ritchie DJ, Reichley RM, Dunne WM, Kollef MH: Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii. Pharmacotherapy. 2007, 27 (2): 191-199. 10.1592\/phco.27.2.191.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"647_CR23","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1089\/mdr.2011.0126","volume":"18","author":"HS Cheong","year":"2012","unstructured":"Cheong HS, Ko KS, Kang CI, Chung DR, Peck KR, Song JH: Clinical significance of infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC beta-lactamase. Microb Drug Resist. 2012, 18 (4): 446-452. 10.1089\/mdr.2011.0126.","journal-title":"Microb Drug Resist"},{"issue":"12","key":"647_CR24","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1086\/502004","volume":"23","author":"SH Choi","year":"2002","unstructured":"Choi SH, Kim YS, Chung JW, Kim TH, Choo EJ, Kim MN, Kim BN, Kim NJ, Woo JH, Ryu J: Serratia bacteremia in a large university hospital: trends in antibiotic resistance during 10\u00a0years and implications for antibiotic use. Infect Control Hosp Epidemiol. 2002, 23 (12): 740-747. 10.1086\/502004.","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"647_CR25","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1086\/423382","volume":"39","author":"CI Kang","year":"2004","unstructured":"Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Oh MD, Kim EC, Choe KW: Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome. Clin Infect Dis. 2004, 39 (6): 812-818. 10.1086\/423382.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"647_CR26","first-page":"328","volume":"39","author":"IK Lee","year":"2006","unstructured":"Lee IK, Liu JW: Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia. J Microbiol Immunol Infect. 2006, 39 (4): 328-334.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"647_CR27","first-page":"67","volume":"39","author":"YC Lin","year":"2006","unstructured":"Lin YC, Chen TL, Ju HL, Chen HS, Wang FD, Yu KW, Liu CY: Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia. J Microbiol Immunol Infect. 2006, 39 (1): 67-72.","journal-title":"J Microbiol Immunol Infect"},{"issue":"1","key":"647_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jhin.2004.04.019","volume":"58","author":"CP Liu","year":"2004","unstructured":"Liu CP, Wang NY, Lee CM, Weng LC, Tseng HK, Liu CW, Chiang CS, Huang FY: Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multiresistant isolates in a medical centre. J Hosp Infect. 2004, 58 (1): 63-77. 10.1016\/j.jhin.2004.04.019.","journal-title":"J Hosp Infect"},{"issue":"5","key":"647_CR29","first-page":"350","volume":"38","author":"HI Shih","year":"2005","unstructured":"Shih HI, Lee HC, Lee NY, Chang CM, Wu CJ, Wang LR, Ko NY, Ko WC: Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance. J Microbiol Immunol Infect. 2005, 38 (5): 350-357.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"647_CR30","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/01.CCM.0000119424.31648.1E","volume":"32","author":"KB Laupland","year":"2004","unstructured":"Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL: Severe bloodstream infections: a population-based assessment. Crit Care Med. 2004, 32 (4): 992-997. 10.1097\/01.CCM.0000119424.31648.1E.","journal-title":"Crit Care Med"},{"issue":"11","key":"647_CR31","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1086\/375057","volume":"36","author":"TP Lodise","year":"2003","unstructured":"Lodise TP, McKinnon PS, Swiderski L, Rybak MJ: Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia. Clin Infect Dis. 2003, 36 (11): 1418-1423. 10.1086\/375057.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"647_CR32","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1097\/01.CCM.0000227655.41566.3E","volume":"34","author":"GE Schramm","year":"2006","unstructured":"Schramm GE, Johnson JA, Doherty JA, Micek ST, Kollef MH: Methicillin-resistant staphylococcus aureus sterile-site infection: the importance of appropriate initial antimicrobial treatment. Crit Care Med. 2006, 34 (8): 2069-2074. 10.1097\/01.CCM.0000227655.41566.3E.","journal-title":"Crit Care Med"},{"issue":"2","key":"647_CR33","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1093\/jac\/dkh366","volume":"54","author":"SH Kim","year":"2004","unstructured":"Kim SH, Park WB, Lee KD, Kang CI, Bang JW, Kim HB, Kim EC, Oh MD, Choe KW: Outcome of inappropriate initial antimicrobial treatment in patients with methicillin-resistant Staphylococcus aureus bacteraemia. J Antimicrob Chemother. 2004, 54 (2): 489-497. 10.1093\/jac\/dkh366.","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"647_CR34","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1086\/374621","volume":"187","author":"KB Laupland","year":"2003","unstructured":"Laupland KB, Church DL, Mucenski M, Sutherland LR, Davies HD: Population-based study of the epidemiology of and the risk factors for invasive Staphylococcus aureus infections. J Infect Dis. 2003, 187 (9): 1452-1459. 10.1086\/374621.","journal-title":"J Infect Dis"},{"issue":"9","key":"647_CR35","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1128\/AAC.01553-07","volume":"52","author":"MY Lin","year":"2008","unstructured":"Lin MY, Weinstein RA, Hota B: Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob Agents Chemother. 2008, 52 (9): 3188-3194. 10.1128\/AAC.01553-07.","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"647_CR36","doi-asserted-by":"publisher","first-page":"3355","DOI":"10.1128\/AAC.00466-06","volume":"50","author":"KK Scarsi","year":"2006","unstructured":"Scarsi KK, Feinglass JM, Scheetz MH, Postelnick MJ, Bolon MK, Noskin GA: Impact of inactive empiric antimicrobial therapy on inpatient mortality and length of stay. Antimicrob Agents Chemother. 2006, 50 (10): 3355-3360. 10.1128\/AAC.00466-06.","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"647_CR37","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1007\/s00134-012-2695-9","volume":"38","author":"A Tabah","year":"2012","unstructured":"Tabah A, Koulenti D, Laupland K, Misset B, Valles J, BruzzideCarvalho F, Paiva JA, Cakar N, Ma X, Eggimann P, Antonelli M, Bonten MJ, Csomos A, Krueger WA, Mikstacki A, Lipman J, Depuydt P, Vesin A, Garrouste-Orgeas M, Zahar JR, Blot S, Carlet J, Brun-Buisson C, Martin C, Rello J, Dimopoulos G, Timsit JF: Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med. 2012, 38 (12): 1930-1945. 10.1007\/s00134-012-2695-9.","journal-title":"Intensive Care Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-014-0647-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0647-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0647-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-014-0647-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T12:44:01Z","timestamp":1551185041000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-014-0647-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["647"],"URL":"https:\/\/doi.org\/10.1186\/s12879-014-0647-4","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"27 December 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"647"}}